Evaluation of the Effect of Pentoxifylline on Inflammatory Biomarker Serum Levels in Patients withBurn Injuries above 40%
Message:
Abstract:
Introduction
One of the important mechanisms of injury in patients with severe burn trauma is an inflammatory response. The results of several studies showed that methods trying to reduce the levels of pivotal proinflammatory factors in such patients may enhance survival and decrease the occurrence of early and late complications. Pentoxifylline is a well-known medication in terms of acting against proinflammatory factors. It is still unknown whether the administration of this drug in patients with burn injuries may have beneficial outcomes or not. Therefore, this study aimed to evaluate this hypothesis in patients with burn injuries over 40%.
Methods and Materials
 In this randomized controlled clinical trial, a total of 80 patients with burn injuries over 40% of body surface area were randomly assigned into groups of experimental (receiving oral pentoxifylline 400 mg/three times a day) and placebo. Serum levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) were compared between the two groups on days 3, 5 and 7. Other variables included the duration of hospital stay, intensive care unit (ICU) stay, mechanical ventilation, and patient’s outcome during hospitalization. Ethics code: 94/3-12/15, Clinical trial: IRCT2017050133737N1
Findings
According to the results, the two groups were similar in terms of age, gender, and the extent of burn injuries. There were no significant differences between the two groups regarding the mean duration time of hospital stay, ICU stay, or outcome during hospitalization. However, the mean duration of mechanical ventilation was significantly shorter in the experimental group (1.42 days vs. 2.85 days, P=0.03). Although a significant decrease was observed in serum levels of IL-6 and TNFα in two groups during the hospital stay, the drop in IL-6 level was significantly more prominent in the experimental group, compared to control group(P=0.01).
Discussion & Conclusions
Pentoxifylline may decrease the duration of mechanical ventilation and hasten the drop of IL-6 serum level in patients with burn injuries over 40%.
Article Type:
Research/Original Article
Language:
Persian
Published:
Ilam University of Medical Science, Volume:27 Issue: 2, 2019
Pages:
93 - 101
magiran.com/p2004691  
برخی از خدمات از جمله دانلود متن مقالات تنها به مشترکان مگیران ارایه می‌گردد. شما می‌توانید به یکی از روش‌های زیر مشترک شوید:
اشتراک شخصی
در سایت عضو شوید و هزینه اشتراک یک‌ساله سایت به مبلغ 300,000ريال را پرداخت کنید. همزمان با برقراری دوره اشتراک بسته دانلود 100 مطلب نیز برای شما فعال خواهد شد!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی همه کاربران به متن مطالب خریداری نمایند!
توجه!
  • دسترسی به متن مقالات این پایگاه در قالب ارایه خدمات کتابخانه دیجیتال و با دریافت حق عضویت صورت می‌گیرد و مگیران بهایی برای هر مقاله تعیین نکرده و وجهی بابت آن دریافت نمی‌کند.
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.